ClinicalTrials.Veeva

Menu

Decidual Stromal Cells as Treatment for Acute Graft Versus Host Disease, a Phase 1-2 Study

Karolinska Institute logo

Karolinska Institute

Status and phase

Unknown
Phase 2
Phase 1

Conditions

Graft vs Host Disease

Treatments

Biological: Decidual Stromal Cells thawed in plasma
Biological: Decidual Stromal Cells thawed in human albumin

Study type

Interventional

Funder types

Other

Identifiers

NCT02172937
DSCGVHD002

Details and patient eligibility

About

The purpose of this study is to evaluate safety and efficacy using decidual stromal cell therapy for graft versus host disease after allogeneic hematopoietic stem cell transplantation. The hypothesis to be tested is that the cells are safe to infuse and that they have a positive clinical effect.

Full description

Patients with GVHD grade 2-4, will receive decidual stromal cells at approximately 1-2x10^6 cells/kg at one or more occasions dependent on clinical response.

Enrollment

50 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute graft versus host disease grade 2-4.
  • Are on calcineurin inhibitor and high dose corticosteroids.

Exclusion criteria

None.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Decidual Stromal Cells as last line treatment
Experimental group
Description:
Patients with therapy-refractory GVHD and on calcineurin inhibitor and high dose corticosteroids without any signs of improvement will be given DSCs to evaluate a possible effect. DSCs will be thawed from the freezer in plasma.
Treatment:
Biological: Decidual Stromal Cells thawed in plasma
Decidual Stromal Cells
Active Comparator group
Description:
Patients with therapy-refractory GVHD and on calcineurin inhibitor and high dose corticosteroids will be given DSCs as early as possible at one or more occasions at weekly intervals dependent on clinical response. DSCs will be thawed from the freezer in plasma.
Treatment:
Biological: Decidual Stromal Cells thawed in human albumin

Trial contacts and locations

1

Loading...

Central trial contact

Helen Kaipe, PhD; Olle Ringdén, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems